AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ChemoMetec Earnings Release 2025

Jul 1, 2025

3356_iss_2025-07-01_37227bb3-fc58-4612-82f6-13b952ff01b1.pdf

Earnings Release

Open in viewer

Opens in your device viewer

1 July 2025

Preliminary revenue figures for the 2024/25 financial year

Based on the preliminary financial figures, ChemoMetec now expects revenue of around DKK 496 million for the financial year 2024/25, against the previously announced DKK 470-490 million.

ChemoMetec's annual report for 2024/25 is scheduled to be released on 11 September 2025.

Additional information

Martin Helbo Behrens, CEO Tel.: (+45) 48 13 10 20

Kim Nicolajsen, CFO Tel.: (+45) 48 13 10 20

About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements.

ChemoMetec's instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec's customers include some of the world's leading pharmaceutical companies.